Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Clinics ; 68(9): 1255-1262, set. 2013. graf
Artículo en Inglés | LILACS | ID: lil-687753

RESUMEN

OBJECTIVE: The aim of this study was to evaluate the effect of a novel phytoestrogen, α-Zearalanol, on Alzheimer's disease-related memory impairment and neuronal oxidation in ovariectomized mice. METHODS: Female C57/BL6 mice were ovariectomized or received sham operations and treatment with equivalent doses of 17β-estradiol or α-Zearalanol for 8 weeks. Their spatial learning and memory were analyzed using the Morris water maze test. The antioxidant enzyme activities and reactive oxygen species generation, neuronal DNA oxidation, and MutT homolog 1 expression in the hippocampus were measured. RESULTS: Treatment with 17β-estradiol or α-Zearalanol significantly improved spatial learning and memory performance in ovariectomized mice. In addition, 17β-estradiol and α-Zearalanol attenuated the decrease in antioxidant enzyme activities and increased reactive oxygen species production in ovariectomized mice. The findings indicated a significant elevation in hippocampi neuronal DNA oxidation and reduction in MutT homolog 1 expression in estrogen-deficient mice, but supplementation with 17β-estradiol or α-Zearalanol efficaciously ameliorated this situation. CONCLUSION: These results demonstrate that α-Zearalanol is potentially beneficial for improving memory impairments and neuronal oxidation damage in a manner similar to that of 17β-estradiol. Therefore, the compound may be a potential therapeutic agent that can ameliorate neurodegenerative disorders related to estrogen deficiency. .


Asunto(s)
Animales , Femenino , Ratones , Enfermedad de Alzheimer/tratamiento farmacológico , Estradiol/uso terapéutico , Trastornos de la Memoria/tratamiento farmacológico , Ovariectomía , Estrés Oxidativo/efectos de los fármacos , Fitoestrógenos/uso terapéutico , Zeranol/análogos & derivados , Western Blotting , Daño del ADN/efectos de los fármacos , Enzimas Reparadoras del ADN/análisis , Hipocampo/efectos de los fármacos , Inmunohistoquímica , Monoéster Fosfórico Hidrolasas/análisis , Reproducibilidad de los Resultados , Factores de Tiempo , Resultado del Tratamiento , Zeranol/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA